Why Prestige Consumer Healthcare Inc.’s (PBH) Stock Is Up 6.30%
As of Wednesday, November 18, Prestige Consumer Healthcare Inc.’s PBH share price has surged by 6.30%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Tudor Pop
Michael Rose
Rosalio Madrigal
| Share Statistics | PBH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,352.3 | $421.5 | 58% |
|
| Shares Out (Mil) | 47.6 | 46.9 | 46% |
|
| Institutional Ownership | 98.8% | 82.0% | 82% |
|
| Float (Mil) | 46.7 | 49.2 | 45% |
|
| Beta | 0.30 | 0.68 | 17% |
|
| Avg Daily Volume (000s) | 547 | 347 | 59% |
|
| Price Change (52-week) |
(15.2%) | 49.3% | 41% |
|
| Growth | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.9% | 6.4% | 28% |
|
| Net Income (5yr) | 2.9% | (1.3%) | 44% |
|
| EPS (5yr) | 3.8% | 15.1% | 37 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 10.8% | (15.0%) | 69% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 7 | 8 | |
| Current EPS | $1.052 | $4.497 | $5.085 | |
| Month Ago EPS | $1.241 | $4.568 | $5.081 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $1.241 | $4.568 | $5.081 | |
| Year/Year Chg | 98.5% | 15.0% | 37.9% | |
| Financials | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,167 | $275 | 52% |
|
| Net Income (TTM) (Mil) | $155 | ($11) | 64% |
|
| EPS (TTM) | $3.260 | ($0.700) | 79% |
|
| Operating Cash Flow (TTM) (Mil) | $230 | ($7) | 60% |
|
| Net Cash Flow (TTM) (Mil) | ($73) | $1 | 18% |
|
| Long-Term Debt (Q1) (Mil) | $2,113 | $6 | 75% |
|
| Enterprise Value (Q1) (Mil) | $4,212 | $331 | 60% |
|
| Valuation | PBH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.21 | 2.08 | 37% |
|
| P/E | 15.3 | 20.9 | 44% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 4.0 | 1.1 | 86% |
|
| Ratios | PBH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.9% | 69.5% | 67% |
|
| Net Margin | 13.3% | 3.6% | 69% |
|
| ROA | 3.8% | (23.8%) | 65% |
|
| ROE | 8.2% | (24.2%) | 51% |
|
| Liabilities to Assets | 58.8% | 31.6% | 53% |
|
| F-Score | 4 | 3 | 33% |
|
Prestige Consumer Healthcare Inc. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors